100 related articles for article (PubMed ID: 10377)
1. Comparison of the dopaminergic effects of N-substituted aporphines.
Menon MK; Clark WG; Cannon JG
J Pharm Pharmacol; 1976 Oct; 28(10):778-81. PubMed ID: 10377
[No Abstract] [Full Text] [Related]
2. Preparation of 7-oxaaporphine derivatives and evaluation of their dopaminergic activity.
Banzatti C; Carfagna N; Commisso R; Heidempergher F; Pegrassi L; Melloni P
J Med Chem; 1988 Jul; 31(7):1466-71. PubMed ID: 2968456
[TBL] [Abstract][Full Text] [Related]
3. Aporphines, 21. (1,2) Dopaminergic activity of aporphine and benzylisoquinoline derivatives. Synthesis of 8-hydroxyaporphines and 1-(hydroxybenzyl)-2-n-propyl-1,2,3,4-tetrahydroisoquinolines.
Costall B; Naylor RJ
J Med Chem; 1977 Feb; 20(2):190-6. PubMed ID: 556776
[TBL] [Abstract][Full Text] [Related]
4. Dissociation between behavioral effects of (-)-N-(2-chloroethyl)-norapomorphine and D2 dopamine receptor-like activity.
Helmeste DM
Eur J Pharmacol; 1983 Nov; 95(3-4):277-81. PubMed ID: 6317413
[TBL] [Abstract][Full Text] [Related]
5. On the ability of N-chloroethyl aporphine derivatives to cause irreversible inhibition of dopamine receptor mechanisms.
Costall B; Fortune DH; Granchelli FE; Law SJ; Naylor RJ; Neumeyer JL; Nohria V
J Pharm Pharmacol; 1980 Aug; 32(8):571-6. PubMed ID: 6106696
[No Abstract] [Full Text] [Related]
6. Behavioral activity of some novel aporphines in rats with 6-hydroxydopamine lesions of caudate or nucleus accumbens.
Jackson EA; Neumeyer JL; Kelly PH
Eur J Pharmacol; 1983 Jan; 87(1):15-23. PubMed ID: 6404639
[TBL] [Abstract][Full Text] [Related]
7. Motor inhibition induced by aporphine derivatives in the mouse.
Bradbury AJ; Costall B; Naylor RJ; Neumeyer JL
J Pharm Pharmacol; 1983 Aug; 35(8):494-9. PubMed ID: 6137533
[No Abstract] [Full Text] [Related]
8. Effects of aporphine and emetine alkaloids on central dopaminergic mechanisms in rats.
Lal S; Sourkes TL; Missala K; Belendiuk G
Eur J Pharmacol; 1972 Oct; 20(1):71-9. PubMed ID: 4674034
[No Abstract] [Full Text] [Related]
9. Proceedings: Effect of aporphine alkaloids on central dopamine receptors.
Kelly PH; Miller RJ; Neumeyer JL
Br J Pharmacol; 1975 Jun; 54(2):271P. PubMed ID: 1148551
[No Abstract] [Full Text] [Related]
10. Aporphines. 11. Synthesis and dopaminergic acitivity of monohydroxyaporphines. Total synthesis of (plus, minus)-11-hydroxyaporphine, (plus and minus)-11-hydroxynoraporphine, and (plus, minus)-11-hydroxy-N-n-propylnoraporphine.
Neumeyer JL; Granchelli FE
J Med Chem; 1974 Oct; 17(10):1090-5. PubMed ID: 4423376
[No Abstract] [Full Text] [Related]
11. [Central depletion of transmitters by reserpine and motor behavior in the rat (author's transl)].
Funk KF; Schmidt J; Westermann KH
Acta Biol Med Ger; 1980; 39(8-9):923-7. PubMed ID: 7282222
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and dopamine receptor binding of sulfur-containing aporphines.
Tóth M; Berényi S; Csutorás C; Kula NS; Zhang K; Baldessarini RJ; Neumeyer JL
Bioorg Med Chem; 2006 Mar; 14(6):1918-23. PubMed ID: 16290940
[TBL] [Abstract][Full Text] [Related]
13. Dopamine autoreceptors differ pharmacologically from postsynaptic dopamine receptors: effects of (-)-N-(2-chloroethyl)-norapomorphine.
Lehmann J; Langer SZ
Eur J Pharmacol; 1982 Jan; 77(1):85-6. PubMed ID: 7060630
[No Abstract] [Full Text] [Related]
14. Comparative assessment of dopamine agonist aporphines as anticonvulsants in two models of reflex epilepsy.
Anlezark GM; Blackwood DH; Meldrum BS; Ram VJ; Neumeyer JL
Psychopharmacology (Berl); 1983; 81(2):135-9. PubMed ID: 6415743
[TBL] [Abstract][Full Text] [Related]
15. Aporphines. 30. (-)-N(2-chloroethyl)-10,11-dihydroxynor-aporphine (chloroethylnorapomorphine), a novel irreversible dopamine receptor antagonist.
Neumeyer JL; Law SJ; Baldessarini RJ; Kula NS
J Med Chem; 1980 Jun; 23(6):594-5. PubMed ID: 7392026
[No Abstract] [Full Text] [Related]
16. Dopamine agonists: structure-activity relationships.
Cannon JG
Prog Drug Res; 1985; 29():303-414. PubMed ID: 3911262
[No Abstract] [Full Text] [Related]
17. Aporphines as antagonists of dopamine D-1 receptors.
Schaus JM; Titus RD; Foreman MM; Mason NR; Truex LL
J Med Chem; 1990 Feb; 33(2):600-7. PubMed ID: 2405158
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic nature of apomorphine-induced pecking in pigeons.
Cheng HC; Long JP
Eur J Pharmacol; 1974 May; 26(2):313-20. PubMed ID: 4851427
[No Abstract] [Full Text] [Related]
19. Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice.
Ferré S; Herrera-Marschitz M; Grabowska-Andén M; Ungerstedt U; Casas M; Andén NE
Eur J Pharmacol; 1991 Jan; 192(1):25-30. PubMed ID: 1828236
[TBL] [Abstract][Full Text] [Related]
20. Aporphines. 8. Total synthesis and pharmacological evaluation of (plus or minus)-apomorphine, (plus or minus)-apocodeine, (plus or minus)-N-n-propylnorapomorphine, and (plus or minus)-N-n-propylnorapocodeine.
Neumeyer JL; Neustadt BR; Oh KH; Weinhardt KK; Boyce CB; Rosenberg FJ; Teiger DG
J Med Chem; 1973 Nov; 16(11):1223-8. PubMed ID: 4201182
[No Abstract] [Full Text] [Related]
[Next] [New Search]
